Sort
17,828 grants matching “crispr”
Epigenetic Maintenance of Neural Cell Identity
$412,500Oliver Bell · University Of Southern California · R01 · FY2022 · MH
Defining the signaling pathways that direct adult tissue stem cells to exit multipotency
$412,500Piyush Gupta · Tufts University Boston · R01 · FY2019 · GM
Investigating stem and progenitor cell quality assurance in development andregeneration.
$412,500Samuel Wattrus · Massachusetts General Hospital · R35 · FY2025 · GM
Opioid Peptide Synthesizing Enzymes
$412,096Iris Lindberg · University Of Maryland Baltimore · R01 · FY2020 · DA
Opioid Peptide Synthesizing Enzymes
$412,096Iris Lindberg · University Of Maryland Baltimore · R01 · FY2019 · DA
Mechanisms of Primary Cilium Assembly and Disassembly
$412,000David King Breslow · Yale University · R35 · FY2021 · GM
Engineering Highly Specific and Orthogonal CRISPR-Cas Systems
$412,000Chase L Beisel · North Carolina State University · · FY2014 · ENG
Cancer Biology in the Zebrafish
$411,968Leonard I Zon · Boston Children'S Hospital · R01 · FY2022 · CA
Rab GTPases-mediated mitochondrial clearance in diabetic cardiomyopathy
$411,962Sang Ging Ong · University Of Illinois At Chicago · R01 · FY2024 · HL
Rab GTPases-mediated mitochondrial clearance in diabetic cardiomyopathy
$411,962Sang Ging Ong · University Of Illinois At Chicago · R01 · FY2020 · HL
Rab GTPases-mediated mitochondrial clearance in diabetic cardiomyopathy
$411,962Sang Ging Ong · University Of Illinois At Chicago · R01 · FY2023 · HL
Rab GTPases-mediated mitochondrial clearance in diabetic cardiomyopathy
$411,962Sang Ging Ong · University Of Illinois At Chicago · R01 · FY2022 · HL
Rab GTPases-mediated mitochondrial clearance in diabetic cardiomyopathy
$411,962Sang Ging Ong · University Of Illinois At Chicago · R01 · FY2021 · HL
Core B: Gene Modulation with RNAi and CRISPER
$411,783Christopher Vakoc · Cold Spring Harbor Laboratory · P01 · FY2019 · CA
IGF-2R is a new therapeutic target for cardiac ischemia-reperfusion injury
$411,747Yigang Wang · University Of Cincinnati · R01 · FY2020 · HL
IGF-2R is a new therapeutic target for cardiac ischemia-reperfusion injury
$411,747Yigang Wang · University Of Cincinnati · R01 · FY2021 · HL
Optimized Gene Replacement for AAT deficiency and Modeling of Clinical Outcomes in small and large animal models
$411,484Terence R. Flotte · Univ Of Massachusetts Med Sch Worcester · P01 · FY2024 · HL
Developmental control of chromatin states in cancer
$411,481Ian J Davis · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
The Metabolic Pathogenesis of Chromophobe Renal Cell Carcinoma
$411,468Elizabeth P Henske · Brigham And Women'S Hospital · R01 · FY2019 · CA
IGF-2R is a new therapeutic target for cardiac ischemia-reperfusion injury
$411,432Yigang Wang · University Of Cincinnati · R01 · FY2019 · HL
Developing KSHV-Infected Lymphatic Endothelial Cell-Based Models of Kaposiâs Sarcoma
$411,400Eva Henriette Gottwein · Northwestern University At Chicago · R21 · FY2024 · CA
Identifying the Drivers and Targeting Chemo Resistance in Ovarian Cancer
$411,369Mazhar Adli · Northwestern University At Chicago · R01 · FY2020 · CA
Project 2 Josefowicz
$411,265Steven Zvi Josefowicz · Weill Medical Coll Of Cornell Univ · P01 · FY2024 · CA
Epigenetic Therapy to Treat Radiation-induced Xerostomia
$411,263Isabelle M.a. Lombaert · University Of Michigan At Ann Arbor · R01 · FY2024 · DE
Roles of Chromatin Remodeler CHD2 in Diffuse Midline Glioma with Onco-Histone Mutations
$411,250Zhiguo Zhang · Columbia University Health Sciences · R01 · FY2023 · NS